PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
12-Jul-2023  PAION AG SUCCESSFULLY HOLDS ITS ANNUAL GENERAL MEETING 2023 PAION AG
12-Jul-2023 Cannovum Cannabis AG: Cooperation with Osnabrück University of Applied Sciences Cannovum Cannabis AG
12-Jul-2023 Kinarus Therapeutics Announces Personnel Changes Kinarus Therapeutics Holding AG
11-Jul-2023 Abivax announces the appointment of June Lee, M.D. and Troy Ignelzi as Members of the Board of Directors ABIVAX
11-Jul-2023 Neuraxpharm expands outside Europe into Brazil and Mexico Neuraxpharm Group
11-Jul-2023 Mallia Therapeutics Secures Seed Funding for its Novel Topical Treatment to Induce Hair Growth via Immune Modulation Mallia Therapeutics GmbH
11-Jul-2023 ABPI response to BGMA Judicial Review dismissal ABPI
11-Jul-2023 UK immersive technology company to create mixed reality training platform for biopharmaceutical and healthcare sectors FourPlus
11-Jul-2023 Avantor Inaugurates Expanded Singapore Hub Avantor
11-Jul-2023 Evotec and Bristol Myers Squibb enter licence agreement within neuroscience partnership Evotec SE
11-Jul-2023 AEVIS VICTORIA SA – Visana Beteiligungen AG becomes a shareholder of Swiss Medical Network SA AEVIS VICTORIA SA
10-Jul-2023 APONTIS PHARMA: CEO Karlheinz Gast resigns for personal reasons - Bruno Wohlschlegel takes over as successor APONTIS PHARMA AG
10-Jul-2023 APONTIS PHARMA AG: CEO Karlheinz Gast resigns from office for personal reasons APONTIS PHARMA AG
10-Jul-2023 Original-Research: MPH Health Care AG (von First Berlin Equity Research GmbH) MPH Health Care AG
10-Jul-2023 Biophytis has filed with the FDA for authorization to initiate SARA-31 phase 3 study in sarcopenia Biophytis
06-Jul-2023 DocMorris AG: DocMorris demands fully digital non-discriminatory access to e-prescriptions DocMorris AG
06-Jul-2023 Hardman & Co Q&A on Real Estate Credit Investments (RECI): Stable dividends since 2013 Hardman & Co Research
06-Jul-2023 Pharma Targeting Launch ‘Partner Identifier’ to Intelligently Connect the Dots between Data and Business Opportunity for Pharma Clients Pharma Targeting
06-Jul-2023 Secarna Pharmaceuticals publishes new preclinical data in The Journal of Immunology demonstrating potent therapeutic activity of LNAplus™ ASO targeting NLRP3 in debilitating autoinflammatory diseases Secarna Pharmaceuticals GmbH & Co. KG
06-Jul-2023 Modifying algae to make rare antioxidants in extreme environments Sciad Newswire